Analysts at the major investment banks are generally in agreement with Sanofi CEO Paul Hudson’s assessment of the firm’s Consumer Healthcare (CHC) separation plan as a “win win.”
“Our early take on these strategic actions is that the separation of CHC is the right thing to do strategically,”...







